Skip to main content
. 2017 Nov 1;7:14833. doi: 10.1038/s41598-017-12512-2

Figure 3.

Figure 3

The function of SCARA5 in adipocyte lineage commitment involves FAK-ERK. A33 cells were transfected with si-scramble and si-SCARA5 and differentiated using IBMX, insulin, and dexamethasone (MDI). (a) Cell counts were determined at 0 and 48 h after induction. **P < 0.01. Quantitative data are presented as the mean ± SD (n = 3). (b) DNA contents were analyzed using flow cytometry at the indicated time points. The suppression of SCARA expression abolished mitotic clonal expansion with a notable decrease in the entry of the cells to the G1-S phase. (c) SCARA5, pFAK (Tyr397), FAK, pERK, ERK, pAKT, and AKT were detected by western blotting at the indicated time points. The relative intensity of the western blots was determined in three independent experiments. (d) C3H10T1/2 cells were infected with MSCV or MSCV-SCARA5. After reaching post-confluence, cells were induced to differentiate using an adipocyte differentiation protocol. The expression of SCARA5, FLAG, pFAK (Tyr397), FAK, pERK, ERK, pAKT, and AKT were detected using western blotting at the indicated time points with β-actin as a loading control. The relative intensity of the western blots was determined in three independent experiments.